Element Capital Management’s Pacira BioSciences PCRX Stock Holding History

Element Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9,497	Closed	-$361K	–	595
2019 Q1	$361K	Buy	+9,497	New	+$371K	0.01%	530
2018 Q2	–	Sell	-77,409	Closed	-$2.41M	–	962
2018 Q1	$2.41M	Sell	77,409 -57,175	-42%	-$2.04M	0.06%	145
2017 Q4	$6.14M	Buy	+134,584	New	+$5.33M	0.13%	106

Other funds holding PCRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Element Capital Management's PCRX Position: Q2 2019 in Review

Element Capital Management sold out of Pacira BioSciences (PCRX) in Q2 2019, closing a stake of 9,497 shares — an estimated $361K sold.

Element Capital Management first reported a position in PCRX in Q4 2017 and held it in 3 quarters. The position peaked at $6.14M in Q4 2017. 218 funds tracked by Wall St. Rank hold PCRX as of Q2 2019.

Element Capital Management reported no remaining Pacira BioSciences position as of Q2 2019 after selling out during the quarter.
Element Capital Management sold 9,497 Pacira BioSciences shares in Q2 2019, an estimated $361K.
Element Capital Management first reported a position in Pacira BioSciences in Q4 2017 and held it in 3 quarters.
Element Capital Management's Pacira BioSciences position peaked at $6.14M in Q4 2017.
218 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.